↓ Skip to main content
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (65th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
1 X user
patent
1 patent

Readers on

mendeley
198 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
Ustekinumab Safety in Psoriasis, Psoriatic Arthritis, and Crohn’s Disease: An Integrated Analysis of Phase II/III Clinical Development Programs
Published in
Drug Safety, February 2019
DOI 10.1007/s40264-019-00797-3
Pubmed ID
Authors

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Activity
Login to access the full charts related to this output.
X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 198 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Login to view Mendeley reader trends over time.

Geographical breakdown

Geographical breakdown
Country Count As %
Unknown 198 100%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Researcher 25 13%
Student > Master 22 11%
Student > Bachelor 15 8%
Student > Postgraduate 15 8%
Other 13 7%
Other 32 16%
Unknown 76 38%
Readers by discipline
Readers by discipline Count As %
Medicine and Dentistry 61 31%
Biochemistry, Genetics and Molecular Biology 10 5%
Nursing and Health Professions 10 5%
Pharmacology, Toxicology and Pharmaceutical Science 8 4%
Immunology and Microbiology 5 3%
Other 24 12%
Unknown 80 40%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 July 2022.
All research outputs
#10,554,176
of 34,089,221 outputs
Outputs from Drug Safety
#1,138
of 2,233 outputs
Outputs of similar age
#162,709
of 493,334 outputs
Outputs of similar age from Drug Safety
#17
of 33 outputs
Altmetric has tracked 34,089,221 research outputs across all sources so far. This one has received more attention than most of these and is in the 67th percentile.
So far Altmetric has tracked 2,233 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 13.2. This one is in the 47th percentile – i.e., 47% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 493,334 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 65% of its contemporaries.
We're also able to compare this research output to 33 others from the same source and published within six weeks on either side of this one. This one is in the 45th percentile – i.e., 45% of its contemporaries scored the same or lower than it.